Early clinical effect of cladribine in patients with highly active multiple sclerosis in Mexico.

Autor: Sauri-Suarez S; ISSSTE National Medical Center 20 de noviembre, Mexico City, Mexico Internal Medicine Department, IMSS HGZ 1A Venados, Mexico City, Mexico., Quiñones S; Department of Neurology, ISSSTE National Medical Center 20 de noviembre, Mexico City, Mexico., De la Maza-Flores M; Department of Neurology, Tec-Salud Zambrano-Hellion Hospital, Monterrey, Mexico., Marin-Contreras A; Department of Neurology, Ángeles Metropolitano Hospital, Mexico City, Mexico., Playas-Pérez G; Department of Neurology, General Hospital of Mexico, Mexico City, Mexico., Bertado-Cortes B; Department of Neurology, IMSS Siglo XXI National Medical Center, Mexico City, Mexico., Frias-Marquez F; Department of Neurology, IMSS 45 Regional General Hospital, Guadalajara, Mexico., Zuñiga-García G; Department of Neurology, ISSSTE Regional General Hospital 'Gral. Ignacio Zaragoza', Mexico City, Mexico., Rodriguez-Leal F; Department of Neurology, Tec-Salud Zambrano-Hellion Hospital, Monterrey, Mexico., Blaisdell-Vidal C; Department of Neurology, IMSS 46 Regional General Hospital, Villahermosa, Mexico., Gomez-Figueroa E; Department of Neurology, Civil Hospital of Guadalajara, Guadalajara, Mexico.

Publikováno v: Multiple sclerosis journal - experimental, translational and clinical [Mult Scler J Exp Transl Clin] 2024 Aug 01; Vol. 10 (3), pp. 20552173241260156. Date of Electronic Publication: 2024 Aug 01 (Print Publication: 2024).